Use of recombinant gene delivery vectors for treating or preventing diseases of the eye

US6943153B1 · kind B1 · utility

Assignees

• The Regents of the University of California · US
• Chiron Corporation · US

Inventors

• William Manning · Redwood City, US
• Varavani Dwarki · Pittstown, US
• Katherine Rendahl · Berkeley, US
• Shangzhen Zhou · Alameda, US
• Sheldon S. Miller · Berkeley, US
• Fei Wang · Beijing, CN

Key dates

• Filing date: Sep 20, 2000
• Grant date: Sep 13, 2005
• Expiry date: Jun 16, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2799/025
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Gene delivery vectors, such as, for example, recombinant adeno-associated viral vectors, and methods of using such vectors are provided for use in treating or preventing diseases of the eye.